SCHEMBL15424455

SCHEMBL15424455

CC(C)(C)OC(=O)N[C@H]1CC[C@H](N2CC(O[Si](c3ccccc3)(c3ccccc3)C(C)(C)C)C2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 1/20 0.47
▸ MAOB P27338 1/20 0.47
▸ KMT2A Q03164 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ CKS1B P61024 1/20 0.43
▸ SKP1 P63208 1/20 0.43
▸ SKP2 Q13309 1/20 0.43
▸ DRD2 P14416 3/20 0.42
▸ KCNA3 P22001 1/20 0.42
▸ CCRL2 O00421 1/20 0.42
▸ OPRM1 P35372 1/20 0.41
▸ OPRD1 P41143 1/20 0.41
▸ OPRK1 P41145 1/20 0.41
▸ OGFRL1 Q5TC84 1/20 0.41
▸ JAK1 P23458 5/20 0.41
▸ JAK2 O60674 2/20 0.40
▸ EPHX2 P34913 1/20 0.39
▸ CCR5 P51681 1/20 0.38
▸ NAMPT P43490 1/20 0.38
▸ CACNB4 O00305 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14646990 0.88 KDM1A (0.53) KDM1AMAOBKMT2AL3MBTL1CKS1B
SCHEMBL15080023 0.79 KDM1A (0.48) KDM1AMAOBKMT2AL3MBTL1CKS1B
SCHEMBL25228466 0.78 BTK (0.46) KDM1AMAOBKMT2AL3MBTL1CKS1B
SCHEMBL13275347 0.77 BCHE (0.32) KMT2ACCR5
SCHEMBL13275349 0.77 BCHE (0.32) KMT2ACCR5
SCHEMBL3367617 0.76 KDM1A (0.45) KDM1AMAOBKMT2AL3MBTL1CKS1B
SCHEMBL3367621 0.76 KDM1A (0.45) KDM1AMAOBKMT2AL3MBTL1CKS1B
SCHEMBL4261324 0.76 KDM1A (0.45) KDM1AMAOBKMT2AL3MBTL1CKS1B
SCHEMBL14631539 0.76 BACE1 (0.38) KDM1AMAOBKMT2AEPHX2
SCHEMBL14631540 0.76 BACE1 (0.38) KDM1AMAOBKMT2AEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220106324-A1 DISPIROPYRROLIDINE DERIVATIVES DAIICHI SANKYO COMPANY, LIMITED (JP) 2022-04-07 — — US disclosed
US-20220106324-A1 DISPIROPYRROLIDINE DERIVATIVES DAIICHI SANKYO COMPANY, LIMITED (JP) 2022-04-07 — — US disclosed
US-20140121196-A1 DISPIROPYRROLIDINE DERIVATIVES DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-05-01 — — US disclosed
US-20140121196-A1 DISPIROPYRROLIDINE DERIVATIVES DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-05-01 — — US disclosed
EP-2684880-A1 DISPIROPYRROLIDINE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-01-15 — — EP disclosed
US-8629133-B2 Dispiropyrrolidine derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140121196-A1 DISPIROPYRROLIDINE DERIVATIVES MDM2, TP53, TPD52L2 KDM1A 1246/4885MAOB 4236/4885KMT2A 1870/4885
US-20220106324-A1 DISPIROPYRROLIDINE DERIVATIVES MDM2, TP53, TP53BP1 KDM1A 1256/4885MAOB 4288/4885KMT2A 1997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback